Vascular wall features in arterial hypertension and correction of identified disorders with Ekvator

Ливенцева, М М; Черняк, С В; Nechesova, T.

doi:10.37987/1997-9894.2016.3(199).203582

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Органопротективные свойства фиксированной комбинации лизиноприла и амлодипина (Экватор®) были показаны в 6-месячном исследовании с участием 172 пациентов (статистически значимое снижение показателей гипертрофии ЛЖ и сосудистой жесткости) [6], а также в исследовании [7].…”

Section: таблица 2 соответствующие целевым уровням хс-лпнп уровни хс-...unclassified

How to Reduce High Cardiovascular Risk in Modern Conditions?

Пристром¹,

Колобова²

2022

Кардиология В Беларуси

View full text Add to dashboard Cite

В статье приводится обзор современных рекомендаций Европейского общества кардиологов (ЕОК) 2021 года по сердечно-сосудистой (СС) профилактике. Современная концепция снижения СС риска направлена на контроль ключевых факторов риска, вносящих огромный вклад в СС заболеваемость (ССЗ) и смертность. Артериальная гипертензия (АГ) и гиперхолестеринемия (ГХС) в повседневной клинической практике являются наиболее значимыми модифицируемыми основными факторами риска (ФР). Поэтому их контроль как немедикаментозными, так и лекарственными методами крайне важен. Одним из важнейших современных принципов лечения АГ является достижение и поддержание целевого артериального давления (АД) посредством применения предпочтительных комбинаций основных лекарственных средств, преимущественно фиксированных. В медикаментозной коррекции ГХС ведущее значение придается использованию в первую очередь статинов, а при их недостаточном эффекте или непереносимости эзетимиба. Современной особенностью снижения СС риска у пациентов с сахарным диабетом (СД) является применение новых гипогликемических лекарственных средств с доказанной эффективностью в снижении СС риска. The article provides an overview of the current recommendations of the European Society of Cardiology 2021 on cardiovascular prevention. The current concept of cardiovascular risk reduction aims to control the key risk factors that make a huge contribution to cardiovascular morbidity and mortality. Arterial hypertension and hypercholesterolemia in everyday clinical practice are the most significant modifiable major risk factors. Therefore, their control, both non-drug and medical methods, is extremely important. One of the most important modern principles for the treatment of hypertension is the achievement and maintenance of target blood pressure through the use of preferred combinations of essential drugs, mostly fixed doses. In the medical correction of hypercholesterolemia, the leading role is given to the use, first of all, of statins, and in case of their insufficient effect, or intolerance, ezetimibe. A modern feature of reducing cardiovascular risk in patients with diabetes mellitus is the use of new hypoglycemic drugs with proven efficacy in reducing cardiovascular risk.

show abstract

Section: таблица 2 соответствующие целевым уровням хс-лпнп уровни хс-...unclassified

How to Reduce High Cardiovascular Risk in Modern Conditions?

Пристром¹,

Колобова²

2022

Кардиология В Беларуси

View full text Add to dashboard Cite

show abstract

Portable Device use for Arterial Stiffness Determination as a Control Method at the Recovery Stage of Rehabilitation

2022

View full text Add to dashboard Cite

Aim: To create a device for PWPV evaluation which would be cheap and could be easily used not only at the inpatient but also at the restorative outpatient and health-resort stages of rehabilitation. Materials and Methods: The clinical examination included 90 people who were randomized into the group of observation (n=75) with patients of AH various degrees. 15 practically healthy persons were involved into the control group. PWPV was measured using a specially designed device according to the generally accepted carotid-femoral technique. Results: Our results showed that the PWPV of healthy persons measured using original device failed to differ statistically from the literature reference values and indicated the correspondence of the measurements we obtained with the data received using traditional apparatus. Out data of original PWPV measurement obtained from examined and treated patients do not differ from the results obtained in wide range of patients aged from 40 to 70 years with the 1st -2nd stages of AH. Conclusions: We described an efficacy of PWPV determination using an original device. The use of the proposed device does not contradict with the generally accepted method of vascular stiffness measuring and studying. The results obtained on it are comparable with the data of the most used stationary device SphygmoCor for these purposes. The prospects of the device using are without the limitations in patients with vascular diseases at the stage of rehabilitation.

show abstract

Vascular wall features in arterial hypertension and correction of identified disorders with Ekvator

Cited by 2 publications

References 0 publications

How to Reduce High Cardiovascular Risk in Modern Conditions?

How to Reduce High Cardiovascular Risk in Modern Conditions?

Portable Device use for Arterial Stiffness Determination as a Control Method at the Recovery Stage of Rehabilitation

Contact Info

Product

Resources

About